On-line haemodiafiltration decreases serum TNFα levels in haemodialysis patients [3]

Nephrology Dialysis Transplantation

Volumn 18, Issue 2, 2003, Pages 447-448

  Gil, Célia ^a   Lucas, Carlos ^a   Possante, Cristina ^a   Jorge, Cristina ^a   Gomes, Fernanda ^a   Candeias, Maria ^a   Lages, Helena ^a   Arranhado, Emília ^a   Ferreira, Aníbal ^a  

^a HOSPITAL CURRY CABRAL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; POLYSULFONE; TUMOR NECROSIS FACTOR ALPHA;

BIOCOMPATIBILITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOASSAY; KIDNEY AMYLOIDOSIS; LETTER; ONLINE MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

HEMODIAFILTRATION; HUMANS; RENAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037317389     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.2.447     Document Type: Letter

References (5)

1. Pertosa J, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int 2000; 58: S104-S111
2. Panichi V, Migliori M, De Pietro S et al. The link of biocompatibility to cytokine production. Kidney Int 2000; 58: S96-S103
3. Ferreira A, Ghazali A, Galvao J et al. Effect of type of dialysis membrane on bone in haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1230-1238
4. Vilaverde M, Perez-Garcia R, Verde E et al. High-flux polysulfone improves the response to recombinant human erythropoietin (rh-EPO) in patients on long term hemodialysis (HD). Nefrologia 1999; 19: 161-167
5. Gil C, Possante M, Catarino MC et al. Low flux versus high flux membranes in chronic hemodialysis patients (abstract). Nephrol Dial Transplant 1999; 14: A218.